Drug Trial Radar · NCT06742190
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
154
Actual
Start
Dec 18, 2024
Primary completion
Sep 2026
Study completion Dec 2029
Sponsor
- Lead sponsor
- argenxargenx (ARGX)
- Sponsor type
- Industry
- First posted
- Dec 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasiprubart, IVIg) and an open-label part B (empasiprubart). The maximum study duration for participants is up to 49 months. More information can be found here: https://clinicaltrials.argenx.com/empassion
Conditions
- Multifocal Motor Neuropathy (MMN)
- MMN
Interventions
EmpasiprubartBiological
Intravenous infusion of empasiprubart
IVIG (Intravenous Immunoglobulin)Biological
Intravenous infusion of IVIg
Empasiprubart-placeboOther
A placebo resembling the empasiprubart treatment
IVIg-placeboOther
A placebo resembling the IVIg treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in grip strength (4-week average) in the most affected hand at week 24Time frame: Up to 24 weeks
Locations
109 sites in 26 countries. Site status is shown where the registry gives one.
HonorHealth Neurology - Bob Bove Neuroscience Institute - Neurology
Scottsdale, Arizona
The Neurology Group
Pomona, California
Samir Macwan, M.D., Inc.
Rancho Mirage, California
University of California San Francisco
San Francisco, California
University of Colorado - Anschutz Cancer Pavilion (Neuro Onc Clinic)
Aurora, Colorado
Yale University School of Medicine
New Haven, Connecticut
Medstar Health Research Institute
Washington D.C., District of Columbia
EZR Research LLC
Boca Raton, Florida
Healthcare Innovations Institute, LLC
Coral Springs, Florida
University of Miami Miller School of Medicine
Miami, Florida
University of South Florida
Tampa, Florida
Northwestern University
Chicago, Illinois
Indiana University Health Neuroscience Center
Indianapolis, Indiana
University of Kansas Medical Center
Fairway, Kansas
Perelman Center for Advanced Medicine
Columbia, Maryland
UC Irvine - MDA ALS and Neuromuscular Center
Columbia, Maryland
University of Minnesota
Minneapolis, Minnesota
Dent Neurologic Institute Amherst
Amherst, New York
Columbia University Medical Center
New York, New York
University of North Carolina at Chapel Hill
Morrisville, North Carolina
The Cleveland Clinic Foundation
Cleveland, Ohio
Oregon Health and Science University
Portland, Oregon
National Neuromuscular Research Institute
Austin, Texas
NeuroCarePlus
Houston, Texas
Royal Melbourne Hospital
Parkville, Australia
Gold Coast University Hospital
Southport, Australia
Brain and Mind Center
Sydney, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Universitätsklinikum AKH Wien
Vienna, Austria
UZ Antwerpen
Edegem, Belgium
UZ Leuven
Leuven, Belgium
Hôpital de la Citadelle
Liège, Belgium
Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto
Ribeirão Preto, Brazil
Sociedade de Ensino Superior Estacio de Sa Ltda
Rio de Janeiro, Brazil
Escola Bahiana de Medicina e Saude Publica
Salvador, Brazil
PSEG Centro de Pesquisa Clínica
São Paulo, Brazil
Neuro-Outaouais Clinic
Gatineau, Canada
London Health Sciences Centre
London, Canada
St. Paul's Neurology Associates
Vancouver, Canada
Huashan Hospital Fudan University
Shanghai, China
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.